Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Sutro Biopharma, Inc. Income Statement Banner

Sutro Biopharma, Inc. Income Statement

STRO Stock Analysis

Page title

Section title

Breakdown
2016
2017
2018
2019
2020
2021
2022
2023
Total Revenue
59.731M51.741M38.419M42.736M42.722M61.880M67.772M153.731M
Cost of Revenue
43.550M51.897M54.262M65.612M76.961M9.773M8.288M6.816M
Gross Profit
16.181M-156.000k-15.843m-22.876m-34.239m52.107M59.484M146.915M
Operating Expense
58.367M71.013M75.642M98.204M113.779M160.404M196.715M236.193M
Operating Income
1.364M-19.272m-37.223m-55.468m-71.057m-98.524m-128.943m-89.278m
Other Income Expense
87.000K-77.000k1.913M-4.350m0.0000.0000.0000.000
Total Other Income Expense
87.000K-77.000k1.913M-276.000k38.929M-7.014m12.239M677.000K
Pretax Income
1.702M-19.688m-35.317m-55.744m-32.128m-105.538m-116.704m-88.601m
Tax Provision
87.000K535.000K3.529M8.679M4.077M3.137M2.500M18.192M
Net Income
1.702M-19.688m-35.317m-55.744m-36.205m-108.675m-119.204m-106.793m
Basic EPS
0.240-2.810-6.130-2.430-1.110-2.360-2.350-1.780
Diluted EPS
0.240-2.810-6.130-2.430-1.110-2.360-2.350-1.780
Basic Average Shares
6.997M6.997M5.759M22.959M32.573M46.119M50.739M60.164M
Diluted Average Shares
6.997M6.997M5.759M22.959M32.573M46.119M50.739M60.164M
Total Expenses
58.367M71.013M75.642M98.204M113.779M160.404M196.715M243.009M
Interest Income
251.000K273.000K1.616M4.074M1.508M577.000K3.455M14.510M
Interest Expense
0.000612.000K1.623M4.350M4.077M3.137M3.346M23.750M
EBITDA
7.364M-14.086m-29.155m-46.617m-65.252m-93.103m-125.488m-82.462m
Depreciation & Amortization
5.662M4.990M4.539M4.777M4.297M9.773M8.288M6.816M